{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:35:03Z","timestamp":1790552103985,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Republic of China Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111522","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T01:15:05Z","timestamp":1617326105000},"page":"111522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-\u03b2 signaling pathway on interstitial cystitis\/bladder pain syndrome"],"prefix":"10.1016","volume":"138","author":[{"given":"Hung-Jen","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Howe","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"van de Merwe","year":"2008","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00019053-200624010-00005","article-title":"Interstitial cystitis: cost, treatment and co-morbidities in an employed population","volume":"24","author":"Wu","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.biopha.2021.111522_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/nau.24100","article-title":"The misdiagnosis of interstitial cystitis\/bladder pain syndrome in a VA population","volume":"38","author":"Skove","year":"2019","journal-title":"Neurourol. Urodyn."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111522_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis","volume":"26","author":"Birder","year":"2019","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.biopha.2021.111522_bib5","first-page":"331","article-title":"Clinical management of bladder pain syndrome\/interstitial cystitis: a review on current recommendations and emerging treatment options","volume":"12","author":"Colemeadow","year":"2020","journal-title":"Res. Rep. Urol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111522_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","article-title":"Etiology, pathophysiology and biomarkers of interstitial cystitis\/painful bladder syndrome","volume":"295","author":"Patnaik","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.biopha.2021.111522_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int. J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287211398255","article-title":"Role of inflammation in bladder function and interstitial cystitis","volume":"3","author":"Grover","year":"2011","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.biopha.2021.111522_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/865463","article-title":"Evidence for bladder urothelial pathophysiology in functional bladder disorders","volume":"2014","author":"Keay","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2021.111522_bib10","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.12688\/f1000research.16096.1","article-title":"Recent advances in imaging and understanding interstitial cystitis","volume":"7","author":"Tyagi","year":"2018","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/his.13235","article-title":"Histopathological characteristics of interstitial cystitis\/bladder pain syndrome without Hunner lesion","volume":"71","author":"Kim","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.biopha.2021.111522_bib12","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biopha.2021.111522_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111522_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.111522_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2020.00883","article-title":"The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis","volume":"11","author":"Alyaseer","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.1201959","article-title":"Inflammasome-independent NLRP3 augments TGF-beta signaling in kidney epithelium","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib17","doi-asserted-by":"crossref","first-page":"F603","DOI":"10.1152\/ajprenal.00128.2017","article-title":"Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1beta","volume":"313","author":"Hughes","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111522_bib18","first-page":"474","article-title":"Characterizing health care utilization, direct costs, and comorbidities associated with interstitial cystitis: a retrospective claims\u00a0analysis","volume":"23","author":"Tung","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.111522_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/aps.2017.179","article-title":"Curcumin and dietary polyphenol research: beyond drug discovery","volume":"39","author":"Jin","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.biopha.2021.111522_bib20","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin suppresses IL-1beta secretion and prevents inflammation through inhibition of the NLRP3 inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2021.111522_bib21","doi-asserted-by":"crossref","first-page":"39551","DOI":"10.1038\/srep39551","article-title":"Suppression of NLRP3 inflammasome activation ameliorates chronic kidney disease-induced cardiac fibrosis and diastolic dysfunction","volume":"6","author":"Bugyei-Twum","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1478-3231.2007.01453.x","article-title":"Prevention of liver cirrhosis in rats by curcumin","volume":"27","author":"Bruck","year":"2007","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.biopha.2021.111522_bib23","doi-asserted-by":"crossref","first-page":"L616","DOI":"10.1152\/ajplung.00002.2009","article-title":"Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury","volume":"298","author":"Smith","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111522_bib24","doi-asserted-by":"crossref","first-page":"F1422","DOI":"10.1152\/ajprenal.00350.2018","article-title":"Void spot assay: recommendations on the use of a simple micturition assay for mice","volume":"315","author":"Hill","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111522_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224839","article-title":"Histochemical quantification of collagen content in articular cartilage","volume":"14","author":"Rieppo","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2021.111522_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/emmm.201201569","article-title":"Tumour inflammasome-derived IL-1beta recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma","volume":"4","author":"Chen","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41598-020-57839-5","article-title":"Differential expression and localisation of TGF-\u03b2 isoforms and receptors in the murine epididymis!Abstract","volume":"10","author":"Voisin","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.111522_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/modpathol.2009.160","article-title":"Upregulation of vimentin and aberrant expression of E-cadherin\/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome","volume":"23","author":"Liu","year":"2010","journal-title":"Mod. Pathol."},{"issue":"S4","key":"10.1016\/j.biopha.2021.111522_bib29","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/nau.23725","article-title":"Fibrosis and the bladder, implications for function ICI-RS 2017","volume":"37","author":"Fry","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.biopha.2021.111522_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1874312901206010080","article-title":"The role of the NLRP3 inflammasome in fibrosis","volume":"6","author":"Artlett","year":"2012","journal-title":"Open Rheumatol. J."},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biopha.2021.111522_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7876064","article-title":"Curcumin suppresses intestinal fibrosis by inhibition of PPAR\u03b3-mediated epithelial-mesenchymal transition","volume":"2017","author":"Xu","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111522_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5213\/inj.1835062.531","article-title":"Animal modelling of interstitial cystitis\/bladder pain syndrome","volume":"22","author":"Birder","year":"2018","journal-title":"Int. Neurourol. J."},{"issue":"3","key":"10.1016\/j.biopha.2021.111522_bib34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-5347(01)66406-1","article-title":"Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin","volume":"155","author":"Stein","year":"1996","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib35","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1038\/s41598-019-44631-3","article-title":"N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model","volume":"9","author":"Ryu","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/107555303321223035","article-title":"Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)","volume":"9","author":"Chainani-Wu","year":"2003","journal-title":"J. Altern. Complement. Med."},{"issue":"8","key":"10.1016\/j.biopha.2021.111522_bib37","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/nu11081837","article-title":"Curcumin and type 2 diabetes mellitus: prevention and treatment","volume":"11","author":"Pivari","year":"2019","journal-title":"Nutrients"},{"issue":"20","key":"10.1016\/j.biopha.2021.111522_bib38","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111522_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","article-title":"Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice","volume":"46","author":"Prasad","year":"2014","journal-title":"Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.biopha.2021.111522_bib40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","article-title":"Oral bioavailability of curcumin: problems and advancements","volume":"24","author":"Liu","year":"2016","journal-title":"J. Drug Target"},{"issue":"4","key":"10.1016\/j.biopha.2021.111522_bib41","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3892\/mmr.2014.3079","article-title":"Curcumin and its major metabolites inhibit the inflammatory response induced by lipopolysaccharide: translocation of nuclear factor-kappaB as potential target","volume":"11","author":"Zhao","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2021.111522_bib42","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/ijms19061637","article-title":"Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases","volume":"19","author":"Maiti","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:30:51Z","timestamp":1760099451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"alternative-id":["S0753332221003073"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111522","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-\u03b2 signaling pathway on interstitial cystitis\/bladder pain syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111522"}}